Registration is open for SOSV’s Health Tech VC-Founder Matchup. Learn More

Healthcare for all

Team

Sanjeev Saxena

CEO

Ali Muckadam

VR Engineer

Harae Dx

Company details

Harae Dx has developed the world’s fastest, low-cost, portable and automated cancer detection system. Using an exclusively-licensed panel of biomarkers from Lawrence Livermore National Labs and the above technology, Harae Dx has developed the world’s first portable early breast cancer test.

Get In Touch with Harae Dx

Please tell us a little bit about yourself and why you'd like to get connected. Harae Dx + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More